BeiGene Constructs Manufacturing and Clinical R&D Center
BeiGene is constructing a $700 million campus for biologics manufacturing and research in Hopewell, N.J. Sited on 42 acres at the Princeton West Innovation Campus, the next-generation complex will provide 400,000 sf of dedicated space for commercial-stage production of cancer therapies, with up to 16,000 liters of biologics capacity. A 100,000-sf lab building will house clinical R&D suites and collaborative office environments. As BeiGene's U.S.